Haemonetics HAE Institutional Ownership

Ownership Summary

Haemonetics Corp (NYSE:HAE) has 320 institutional investors that have filed 13F reports for the period ending March 2026.

• Their combined ownership stood at 100.8% of outstanding shares in March 2026, down from 112.4% in December 2025.
• They increased total shares held in Haemonetics by 3.03% from the prior quarter, while the number of investors in HAE increased 0.31% year over year.
• During the quarter, 170 of these 320 funds increased positions in HAE, 112 reduced exposure, and 38 held steady.
• The aggregate institutional position in Haemonetics amounted to 47.54Mn shares as of March 2026, up by 1.4Mn shares quarter on quarter, and down 11.51Mn shares year over year.
• As of March 31, 2026, BlackRock, Inc. held the largest stake in Haemonetics with 5.62Mn shares, accounting for 11.91% of total shares outstanding.
• The most significant purchases of HAE for the quarter ending March 2026 came from VANGUARD PORTFOLIO MANAGEMENT LLC (2.56Mn), VANGUARD CAPITAL MANAGEMENT LLC (2.09Mn), Invenomic Capital Management LP (664.73K), PRICE T ROWE ASSOCIATES INC /MD/ (420.28K), VANGUARD FIDUCIARY TRUST CO (323.58K).
• The biggest sellers of Haemonetics for the quarter ending March 2026 included Goldman Sachs Group Inc (1.5Mn), Holocene Advisors, LP (1.26Mn), T. Rowe Price Investment Management, Inc. (1.19Mn), CITADEL ADVISORS LLC (1.03Mn), Point72 Asset Management, L.P. (796.51K).
• Haemonetics's 10 largest shareholders as of March 2026 include BlackRock, Inc. (5.62Mn), Neuberger Berman Group LLC (3.56Mn), AQR CAPITAL MANAGEMENT LLC (3.36Mn), VANGUARD PORTFOLIO MANAGEMENT LLC (2.56Mn), VANGUARD CAPITAL MANAGEMENT LLC (2.09Mn), State Street Corp (1.77Mn), ARROWSTREET CAPITAL, LIMITED PARTNERSHIP (1.38Mn), River Road Asset Management, LLC (1.33Mn), DIMENSIONAL FUND ADVISORS LP (1.33Mn), FMR LLC (1.28Mn) per Business Quant data.